FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, medicine and molecular biopharmacology. Disclosed is use of a polypeptide having an amino acid sequence corresponding to SEQ ID NO:1 to suppress viability, migration and invasion of squamous cell carcinoma of the oral cavity, reducing expression of oncogenes ITGAV, BCL2 and MMP7.
EFFECT: use of the invention provides higher anticancer efficacy of endostatin protein with respect to squamous cell carcinoma of the oral cavity.
1 cl, 7 dwg
Authors
Dates
2019-11-07—Published
2018-10-26—Filed